Easy Access and Express Report Delivery Service
Table 225. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Embolotherapy Product Picture Figure 5. Global Embolotherapy Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 6. Global Embolotherapy Market Share by Type: 2022 VS 2029 Figure 7. Microspheres for Embolization Product Picture Figure 8. Embolism Particles Product Picture Figure 9. Embolic coils Product Picture Figure 10. Liquid Embolic Agent Product Picture Figure 11. Auxiliary Embolization Material Product Picture Figure 12. Others Product Picture Figure 13. Global Embolotherapy Market Size by Application (2023-2029) & (US$ Million) Figure 14. Global Embolotherapy Market Share by Application: 2022 VS 2029 Figure 15. Cancer Product Picture Figure 16. Peripheral Aascular Disease Product Picture Figure 17. Nerve System Disease Product Picture Figure 18. Others Product Picture Figure 19. Global Embolotherapy Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 20. Global Embolotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 21. Global Embolotherapy Market Share by Region: 2022 VS 2029 Figure 22. Global Embolotherapy Market Share by Players in 2022 Figure 23. Global Embolotherapy Players, Date of Enter into This Industry Figure 24. Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2022 Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 26. North America Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. North America Embolotherapy Market Share by Country (2018-2029) Figure 28. United States Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Canada Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Europe Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Europe Embolotherapy Market Share by Country (2018-2029) Figure 32. Germany Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. France Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. U.K. Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Italy Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Russia Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Nordic Countries Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Asia-Pacific Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Asia-Pacific Embolotherapy Market Share by Country (2018-2029) Figure 40. China Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Japan Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. South Korea Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Southeast Asia Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. India Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Australia Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Latin America Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Latin America Embolotherapy Market Share by Country (2018-2029) Figure 48. Mexico Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Brazil Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 51. Middle East & Africa Embolotherapy Market Share by Country (2018-2029) Figure 52. Turkey Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 53. Saudi Arabia Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 54. UAE Embolotherapy Market Size YoY Growth (2018-2029) & (US$ Million) Figure 55. Medtronic Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 56. Boston Scientific Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 57. Terumo Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 58. Penumbra, Inc. Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 59. Johnson & Johnson Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 60. Sirtex Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 61. Merit Medical Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 62. Varian Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 63. Stryker Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 64. Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 65. Cook Medical Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 66. Kaneka Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 67. Meril Life Sciences Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 68. Peijia Medical Limited Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 69. Wallaby Medical Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 70. MicroPort Scientific Corporation Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 71. Shandong Visee Medical Devices Co.,Ltd Revenue Growth Rate in Embolotherapy Business (2018-2023) Figure 72. Beijing Taijie Weiye Technology Revenue Growth Rate in Embolotherapy Business (2018-2023) Highlights The global Embolotherapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North American market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue. The global market for Embolotherapy in Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029. Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Microspheres for Embolization, which accounted for % of the global market of Embolotherapy in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029. Report Scope This report aims to provide a comprehensive presentation of the global market for Embolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy. The Embolotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Embolotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include: Medtronic Boston Scientific Terumo Penumbra, Inc. Johnson & Johnson Sirtex Merit Medical Varian Stryker Jiangsu Hengrui Pharmaceuticals Co., Ltd Cook Medical Kaneka Meril Life Sciences Peijia Medical Limited Wallaby Medical MicroPort Scientific Corporation Shandong Visee Medical Devices Co.,Ltd Beijing Taijie Weiye Technology Product Type Insights Global markets are presented by Embolotherapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Embolotherapy are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Embolotherapy segment by Type Microspheres for Embolization Embolism Particles Embolic coils Liquid Embolic Agent Auxiliary Embolization Material Others Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Embolotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Embolotherapy market. Embolotherapy Segment by Application Cancer Peripheral Aascular Disease Nerve System Disease Others Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Embolotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This report stays updated with novel technology integration, features, and the latest developments in the market This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Embolotherapy industry. This report helps stakeholders to gain insights into which regions to target globally This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Embolotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report. Frequently Asked Questions What factors will challenge the Product Name market growth? Which end-use segment will expand at the fastest CAGR in the Product Name market? Which are the emerging players in the Product Name market? How concentrated is the Product Name market? Which factors are positively contributing to the Product Name market growth? Which are the novel product innovations in the Product Name market? Which product segment will emerge as the most lucrative in the Product Name market? Which factors are increasing the competition in the Product Name market? Which are the strategic measures taken by the Product Name industry players? Which region will witness inactive growth during the forecast period? What key trends are likely to emerge in the Product Name market in the coming years?
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Embolotherapy by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Microspheres for Embolization 1.2.3 Embolism Particles 1.2.4 Embolic coils 1.2.5 Liquid Embolic Agent 1.2.6 Auxiliary Embolization Material 1.2.7 Others 2.3 Embolotherapy by Application 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) 2.3.2 Cancer 2.3.3 Peripheral Aascular Disease 2.3.4 Nerve System Disease 2.3.5 Others 2.4 Assumptions and Limitations 3 Embolotherapy Breakdown Data by Type 3.1 Global Embolotherapy Historic Market Size by Type (2018-2023) 3.2 Global Embolotherapy Forecasted Market Size by Type (2023-2028) 4 Embolotherapy Breakdown Data by Application 4.1 Global Embolotherapy Historic Market Size by Application (2018-2023) 4.2 Global Embolotherapy Forecasted Market Size by Application (2018-2023) 5 Global Growth Trends 5.1 Global Embolotherapy Market Perspective (2018-2029) 5.2 Global Embolotherapy Growth Trends by Region 5.2.1 Global Embolotherapy Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Embolotherapy Historic Market Size by Region (2018-2023) 5.2.3 Embolotherapy Forecasted Market Size by Region (2024-2029) 5.3 Embolotherapy Market Dynamics 5.3.1 Embolotherapy Industry Trends 5.3.2 Embolotherapy Market Drivers 5.3.3 Embolotherapy Market Challenges 5.3.4 Embolotherapy Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Embolotherapy Players by Revenue 6.1.1 Global Top Embolotherapy Players by Revenue (2018-2023) 6.1.2 Global Embolotherapy Revenue Market Share by Players (2018-2023) 6.2 Global Embolotherapy Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Embolotherapy Head office and Area Served 6.4 Global Embolotherapy Players, Product Type & Application 6.5 Global Embolotherapy Players, Date of Enter into This Industry 6.6 Global Embolotherapy Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Embolotherapy Market Size (2018-2029) 7.2 North America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Embolotherapy Market Size by Country (2018-2023) 7.4 North America Embolotherapy Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Embolotherapy Market Size (2018-2029) 8.2 Europe Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Embolotherapy Market Size by Country (2018-2023) 8.4 Europe Embolotherapy Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Embolotherapy Market Size (2018-2029) 9.2 Asia-Pacific Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Embolotherapy Market Size by Country (2018-2023) 9.4 Asia-Pacific Embolotherapy Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Embolotherapy Market Size (2018-2029) 10.2 Latin America Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Embolotherapy Market Size by Country (2018-2023) 10.4 Latin America Embolotherapy Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Embolotherapy Market Size (2018-2029) 11.2 Middle East & Africa Embolotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Embolotherapy Market Size by Country (2018-2023) 11.4 Middle East & Africa Embolotherapy Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Medtronic 11.1.1 Medtronic Company Detail 11.1.2 Medtronic Business Overview 11.1.3 Medtronic Embolotherapy Introduction 11.1.4 Medtronic Revenue in Embolotherapy Business (2017-2022) 11.1.5 Medtronic Recent Development 11.2 Boston Scientific 11.2.1 Boston Scientific Company Detail 11.2.2 Boston Scientific Business Overview 11.2.3 Boston Scientific Embolotherapy Introduction 11.2.4 Boston Scientific Revenue in Embolotherapy Business (2017-2022) 11.2.5 Boston Scientific Recent Development 11.3 Terumo 11.3.1 Terumo Company Detail 11.3.2 Terumo Business Overview 11.3.3 Terumo Embolotherapy Introduction 11.3.4 Terumo Revenue in Embolotherapy Business (2017-2022) 11.3.5 Terumo Recent Development 11.4 Penumbra, Inc. 11.4.1 Penumbra, Inc. Company Detail 11.4.2 Penumbra, Inc. Business Overview 11.4.3 Penumbra, Inc. Embolotherapy Introduction 11.4.4 Penumbra, Inc. Revenue in Embolotherapy Business (2017-2022) 11.4.5 Penumbra, Inc. Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Detail 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Embolotherapy Introduction 11.5.4 Johnson & Johnson Revenue in Embolotherapy Business (2017-2022) 11.5.5 Johnson & Johnson Recent Development 11.6 Sirtex 11.6.1 Sirtex Company Detail 11.6.2 Sirtex Business Overview 11.6.3 Sirtex Embolotherapy Introduction 11.6.4 Sirtex Revenue in Embolotherapy Business (2017-2022) 11.6.5 Sirtex Recent Development 11.7 Merit Medical 11.7.1 Merit Medical Company Detail 11.7.2 Merit Medical Business Overview 11.7.3 Merit Medical Embolotherapy Introduction 11.7.4 Merit Medical Revenue in Embolotherapy Business (2017-2022) 11.7.5 Merit Medical Recent Development 11.8 Varian 11.8.1 Varian Company Detail 11.8.2 Varian Business Overview 11.8.3 Varian Embolotherapy Introduction 11.8.4 Varian Revenue in Embolotherapy Business (2017-2022) 11.8.5 Varian Recent Development 11.9 Stryker 11.9.1 Stryker Company Detail 11.9.2 Stryker Business Overview 11.9.3 Stryker Embolotherapy Introduction 11.9.4 Stryker Revenue in Embolotherapy Business (2017-2022) 11.9.5 Stryker Recent Development 11.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd 11.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Detail 11.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview 11.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Introduction 11.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2017-2022) 11.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development 11.11 Cook Medical 11.11.1 Cook Medical Company Detail 11.11.2 Cook Medical Business Overview 11.11.3 Cook Medical Embolotherapy Introduction 11.11.4 Cook Medical Revenue in Embolotherapy Business (2017-2022) 11.11.5 Cook Medical Recent Development 11.12 Kaneka 11.12.1 Kaneka Company Detail 11.12.2 Kaneka Business Overview 11.12.3 Kaneka Embolotherapy Introduction 11.12.4 Kaneka Revenue in Embolotherapy Business (2017-2022) 11.12.5 Kaneka Recent Development 11.13 Meril Life Sciences 11.13.1 Meril Life Sciences Company Detail 11.13.2 Meril Life Sciences Business Overview 11.13.3 Meril Life Sciences Embolotherapy Introduction 11.13.4 Meril Life Sciences Revenue in Embolotherapy Business (2017-2022) 11.13.5 Meril Life Sciences Recent Development 11.14 Peijia Medical Limited 11.14.1 Peijia Medical Limited Company Detail 11.14.2 Peijia Medical Limited Business Overview 11.14.3 Peijia Medical Limited Embolotherapy Introduction 11.14.4 Peijia Medical Limited Revenue in Embolotherapy Business (2017-2022) 11.14.5 Peijia Medical Limited Recent Development 11.15 Wallaby Medical 11.15.1 Wallaby Medical Company Detail 11.15.2 Wallaby Medical Business Overview 11.15.3 Wallaby Medical Embolotherapy Introduction 11.15.4 Wallaby Medical Revenue in Embolotherapy Business (2017-2022) 11.15.5 Wallaby Medical Recent Development 11.16 MicroPort Scientific Corporation 11.16.1 MicroPort Scientific Corporation Company Detail 11.16.2 MicroPort Scientific Corporation Business Overview 11.16.3 MicroPort Scientific Corporation Embolotherapy Introduction 11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Business (2017-2022) 11.16.5 MicroPort Scientific Corporation Recent Development 11.17 Shandong Visee Medical Devices Co.,Ltd 11.17.1 Shandong Visee Medical Devices Co.,Ltd Company Detail 11.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview 11.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Introduction 11.17.4 Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2017-2022) 11.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Development 11.18 Beijing Taijie Weiye Technology 11.18.1 Beijing Taijie Weiye Technology Company Detail 11.18.2 Beijing Taijie Weiye Technology Business Overview 11.18.3 Beijing Taijie Weiye Technology Embolotherapy Introduction 11.18.4 Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2017-2022) 11.18.5 Beijing Taijie Weiye Technology Recent Development 13 Report Conclusion 14 Disclaimer